Bernd Hoppe
Directeur/Bestuurslid bij Oxalosis & Hyperoxaluria Foundation
Profiel
Bernd Hoppe is currently the Director at Oxalosis & Hyperoxaluria Foundation.
Previously, he worked as the Vice President-Global Medical Affairs at Dicerna Pharmaceuticals, Inc.
Actieve functies van Bernd Hoppe
| Bedrijven | Functie | Begin |
|---|---|---|
Oxalosis & Hyperoxaluria Foundation
 Oxalosis & Hyperoxaluria Foundation Medical/Nursing ServicesHealth Services The Oxalosis & Hyperoxaluria Foundation is dedicated to eradicating all forms of hyperoxaluria disease forever. The non-profit company is based in New York, NY. The company's vision is a world without hyperoxaluria, and they are committed to improving the daily lives of people with this condition. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Bernd Hoppe
| Bedrijven | Functie | Einde |
|---|---|---|
| DICERNA PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
Oxalosis & Hyperoxaluria Foundation
Oxalosis & Hyperoxaluria Foundation Medical/Nursing ServicesHealth Services The Oxalosis & Hyperoxaluria Foundation is dedicated to eradicating all forms of hyperoxaluria disease forever. The non-profit company is based in New York, NY. The company's vision is a world without hyperoxaluria, and they are committed to improving the daily lives of people with this condition. | Health Services |
